Bloomberg: Denmark’s Lundbeck has explored potential takeover of Xeris Biopharma, but Xeris says it is not for sale
https://finviz.com/stock?t=XERS&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.